Key result
Adult bone marrow stem cell transplantation emerges as a potential modality to improve ischemic myocardial function.
Answers are grounded in this paper and cite their sources.
Coronary artery disease leading to ischaemia of the human myocardium is one of the chief causes of morbidity and mortality in the western world. Cellular transplantation has recently been proposed as a novel alternative treatment modality. Adult bone marrow-derived autologous cells are one of the key cell types under investigation in both the experimental and clinical setting. A range of theories has been proposed with regard to the observed myocardial function improvement in both human and animal studies. A concerted interest in scientific questions needs to be constructed on the regenerative information made available throughout the last years. It is only now that we begin to fully understand this fast growing body of research and how it may have wide ranging implications for the treatment of ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Dimarakis et al. (2005) conducted a review in Ischemic heart disease / coronary artery disease. Adult bone marrow-derived autologous stem cell transplantation was evaluated on Myocardial function improvement. Adult bone marrow-derived stem cell transplantation is being investigated as a novel alternative modality to improve myocardial function in ischemic heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: